Nova Mentis Upgrades U.S. Listing to the OTCQB Venture Market

Group Ketamine-Assisted Psychotherapy: Practice and Promise of a New Frontier

Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.]...

MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes...

The Pitfalls and Challenges of Psychedelic Medicine

Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and...

Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT

Red Light Holland’s Psychedelic Virtual Reality Experience, Wisdom, Narrated by Global...

PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and...

Numinus to expand state-of-the-art psychedelics research laboratory

Load more